Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN

Delayed Quote. Delayed  - 05/27 09:59:59 pm
396.22 USD   +0.68%
05/26 REGENERON PHARM : Selected by Society for Science & the Public as Ne..
05/26 REGENERON PHARM : Words of Support from Public Figures on Regeneron ..
05/26DJREGENERON PHARM : Named as Science Talent Search Sponsor
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/23/2016 05/24/2016 05/25/2016 05/26/2016 05/27/2016 Date
392.64(c) 397.7(c) 394.49(c) 393.54(c) 396.22 Last
1 086 269 1 109 911 960 115 733 390 548 059 Volume
+1.72% +1.29% -0.81% -0.24% +0.68% Change
More quotes
Financials ($)
Sales 2016 5 112 M
EBIT 2016 1 793 M
Net income 2016 761 M
Finance 2016 1 430 M
Yield 2016 -
Sales 2017 6 018 M
EBIT 2017 2 272 M
Net income 2017 1 227 M
Finance 2017 3 538 M
Yield 2017 -
P/E ratio 2016 64,37
P/E ratio 2017 40,41
EV / Sales 2016 7,81x
EV / Sales 2017 6,28x
Capitalization 41 353 M
More Financials
Company
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company.It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.The company involves in marketing medicines for eye diseases, colorectal cancer and a rare inflammatory... 
Sector
Biotechnology & Medical Research
Calendar
06/10 | 04:30pmShareholder meeting
More about the company
Surperformance© ratings of Regeneron Pharmaceuticals
Trading Rating : Investor Rating :
More Ratings
Latest news on REGENERON PHARMACEUTICALS
05/26 REGENERON PHARMACEUTICALS : Selected by Society for Science & the Public as New ..
05/26 REGENERON PHARMACEUTICALS : Words of Support from Public Figures on Regeneron ST..
05/26DJREGENERON PHARMACEUTICALS : Named as Science Talent Search Sponsor
05/25 REGENERON PHARMACEUTICALS : Announces Important US Prescribing Information Clari..
05/25 Top 10 highest-paid CEOs
05/19 REGENERON PHARMACEUTICALS : U.S. Patents Awarded to Inventors in Massachusetts (..
05/19 REGENERON PHARMACEUTICALS : U.S. Patents Awarded to Inventors in New Jersey (May..
05/19 REGENERON PHARMACEUTICALS : Assigned Patent
05/18DJAMGEN : Researchers Discover Gene Associated With Lower Risk of Heart Disease
05/16 Biotechnology Stocks Show Strong Move To The Upside
More news
Sector news : Bio Therapeutic Drugs
02:09p MEDIVATION : Files Preliminary Consent Revocation Statement
01:26p GILEAD SCIENCES : European CHMP Adopts Positive Opinion for Gilead’s Epclu..
05/26 ALDER BIOPHARMACEUTICALS : Continues to Strengthen and Expand Leadership Team to..
05/26DJIonis's Shares Fall After Co-Developer Opts Against Starting Late-Stage Trial
05/26 ALKERMES : Appoints Nancy Snyderman, M.D., to Board of Directors
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
05/25 Best Performing Nasdaq 100 Stocks
05/23 SANOFI : High Quality Product Portfolio But Risks Remain
05/20 FACEBOOK : Overvalued And Over-Owned
05/18 The Celgene-Agios Partnership Strategy
05/18 PIERIS PHARMACEUTICALS : The Blockbuster In Antibody Mimetics
Advertisement
Chart REGENERON PHARMACEUTICALS
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Full-screen chart
Technical analysis trends REGENERON PHARMAC...
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions